The immunology of most autoimmune diseases (e.g., rheumatoid arthritis or inflammatory bowel disease, IBD) is complex and not very well understood, and better tools are needed to study the different immune cell subsets implicated in disease initiation and progression, such as CD4+ T cells [2, 3]. This evidence concerns the gene CD4 and rheumatoid arthritis.